These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32349049)

  • 41. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
    Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
    Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study.
    Ambrosio MR; Rocca BJ; Ginori A; Mourmouras V; Amato T; Vindigni C; Lazzi S; Leoncini L
    Am J Clin Pathol; 2015 Nov; 144(5):817-22. PubMed ID: 26486748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of differential diagnosis of EBV mucocutaneous ulcer and EBV-positive diffuse large B-cell lymphoma: A case report.
    Hong YR; Kwon JS; Ahn HJ; Han SY; Cho E; Kim BE
    Medicine (Baltimore); 2024 Feb; 103(8):e37243. PubMed ID: 38394551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
    Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
    J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings.
    Gong S; Crane GM; McCall CM; Xiao W; Ganapathi KA; Cuka N; Davies-Hill T; Xi L; Raffeld M; Pittaluga S; Duffield AS; Jaffe ES
    Am J Surg Pathol; 2018 Oct; 42(10):1306-1316. PubMed ID: 29957733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
    Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
    Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report.
    Kingma DW; Shad A; Tsokos M; Fest T; Otsuki T; Frekko K; Werner E; Werner A; Magrath I; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1996 Dec; 20(12):1511-9. PubMed ID: 8944045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus infection in Richter's transformation.
    Ansell SM; Li CY; Lloyd RV; Phyliky RL
    Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients.
    Asano N; Yamamoto K; Tamaru J; Oyama T; Ishida F; Ohshima K; Yoshino T; Nakamura N; Mori S; Yoshie O; Shimoyama Y; Morishima Y; Kinoshita T; Nakamura S
    Blood; 2009 Mar; 113(12):2629-36. PubMed ID: 19075188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low incidence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in Tianjin, northern China.
    Pan Y; Meng B; Zhang H; Cao W; Wang H; Bi C; Liu F; Sun B; Hao X; Ai WZ; Fu K
    Leuk Lymphoma; 2013 Feb; 54(2):298-303. PubMed ID: 22830615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
    Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
    Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous manifestations of methotrexate-associated lymphoproliferative disorders: report of two cases and a review of the literature.
    Shimizu S; Inokuma D; Murata J; Kikuchi K; Ito T; Fukasawa Y; Mukai M; Moriuchi R
    Acta Derm Venereol; 2015 Mar; 95(3):366-7. PubMed ID: 25138609
    [No Abstract]   [Full Text] [Related]  

  • 53. Diffuse large B-cell lymphoma involving the central nervous system.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Int J Surg Pathol; 2011 Feb; 19(1):44-50. PubMed ID: 21087986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
    Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
    Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical characteristics and treatment outcome in a Taiwanese population of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Lu CH; Lee KF; Chen CC; Chen YY; Huang CE; Tsai PS; Tsou HY; Chou HJ; Chen MF; Chen PT; Lee KD; Lung J
    Jpn J Clin Oncol; 2014 Dec; 44(12):1164-71. PubMed ID: 25320341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms.
    Abruzzo LV; Rosales CM; Medeiros LJ; Vega F; Luthra R; Manning JT; Keating MJ; Jones D
    Am J Surg Pathol; 2002 May; 26(5):630-6. PubMed ID: 11979093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma.
    Miller IJ
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):165-173. PubMed ID: 28800008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients.
    Okamoto A; Yanada M; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
    Hematol Oncol; 2017 Mar; 35(1):87-93. PubMed ID: 26177728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.